Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annelore Altendorf-Hofmann

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Journal of Cancer Research and Clinical Oncology|April 21, 2021
Surgical treatment of liver metastases from non-colorectal non-neuroendocrine carcinomasAstrid Bauschke, Annelore Altendorf-Hofmann, Merten Homman, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2010
TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 casesThomas Knösel, Sarah Heretsch, Annelore Altendorf-Hofmann, et al.
Journal of Cancer Research and Clinical Oncology|July 2, 2009
Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration databaseOrlando Guntinas-Lichius, Thomas Wendt, Jens Buentzel, et al.
BMC Cancer|December 29, 2017
Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targetsDaniel Kaemmerer, Robin Schindler, Franziska Mußbach, et al.
Journal of Cancer Research and Clinical Oncology|May 9, 2014
High IGF2 and FGFR3 are associated with tumour progression in undifferentiated pleomorphic sarcomas, but EGFR and FGFR3 mutations are a rare eventKatinka Rüping, Annelore Altendorf-Hofmann, Yuan Chen, et al.
British Journal of Cancer|October 16, 2015
Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinomaSteffen Ormanns, Annelore Altendorf-Hofmann, Rene Jackstadt, et al.
Journal of Cancer Research and Clinical Oncology|July 13, 2024
Rare tumours of the pancreas: monocentric studyAstrid Bauschke, Annelore Altendorf-Hofmann, Aladdin Ali-Deeb, et al.
Virchows Archiv : an International Journal of Pathology|June 1, 2012
FGFR1 expression and gene copy numbers in human lung cancerLukas H Kohler, Masoud Mireskandari, Thomas Knösel, et al.
European Journal of Heart Failure|October 10, 2009
Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophyMarcus Franz, Alexander Berndt, Annelore Altendorf-Hofmann, et al.
Journal of Cancer Research and Clinical Oncology|March 28, 2009
B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder?Petra Richter, Markus Tost, Marcus Franz, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Journal of Cancer Research and Clinical Oncology|April 21, 2021
Surgical treatment of liver metastases from non-colorectal non-neuroendocrine carcinomasAstrid Bauschke, Annelore Altendorf-Hofmann, Merten Homman, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2010
TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 casesThomas Knösel, Sarah Heretsch, Annelore Altendorf-Hofmann, et al.
Journal of Cancer Research and Clinical Oncology|July 2, 2009
Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration databaseOrlando Guntinas-Lichius, Thomas Wendt, Jens Buentzel, et al.
BMC Cancer|December 29, 2017
Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targetsDaniel Kaemmerer, Robin Schindler, Franziska Mußbach, et al.
Journal of Cancer Research and Clinical Oncology|May 9, 2014
High IGF2 and FGFR3 are associated with tumour progression in undifferentiated pleomorphic sarcomas, but EGFR and FGFR3 mutations are a rare eventKatinka Rüping, Annelore Altendorf-Hofmann, Yuan Chen, et al.
British Journal of Cancer|October 16, 2015
Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinomaSteffen Ormanns, Annelore Altendorf-Hofmann, Rene Jackstadt, et al.
Journal of Cancer Research and Clinical Oncology|July 13, 2024
Rare tumours of the pancreas: monocentric studyAstrid Bauschke, Annelore Altendorf-Hofmann, Aladdin Ali-Deeb, et al.
Virchows Archiv : an International Journal of Pathology|June 1, 2012
FGFR1 expression and gene copy numbers in human lung cancerLukas H Kohler, Masoud Mireskandari, Thomas Knösel, et al.
European Journal of Heart Failure|October 10, 2009
Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophyMarcus Franz, Alexander Berndt, Annelore Altendorf-Hofmann, et al.
Journal of Cancer Research and Clinical Oncology|March 28, 2009
B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder?Petra Richter, Markus Tost, Marcus Franz, et al.
Pageof 6